-
Je něco špatně v tomto záznamu ?
Modulation of animal and human hematopoiesis by β-glucans: a review
M. Hofer, M. Pospíšil,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- anemie chemicky indukované farmakoterapie MeSH
- beta-glukany škodlivé účinky farmakologie terapeutické užití MeSH
- hematinika škodlivé účinky farmakologie terapeutické užití MeSH
- hematopoéza účinky léků účinky záření MeSH
- lékové formy MeSH
- lidé MeSH
- protinádorové látky škodlivé účinky MeSH
- radioterapie škodlivé účinky MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
β-glucans are cell wall constituents of bacteria, yeast, fungi, and plants. They are not expressed in mammalian cells, but they are recognized by mammalian cells as pathogen-associated molecular patterns by pattern recognition receptors and thus act as biological response modifiers. This review summarizes data on the hematopoiesis-stimulating effects of β-glucans, as well as on their ability to enhance bone marrow recovery after an injury. β-glucans have been shown to support murine hematopoiesis suppressed by ionizing radiation or cytotoxic anti-cancer therapy. They also enhance stem cell homing and engraftment. Basically, two forms of β-glucan preparations have been investigated, namely particulate and soluble ones. β-glucans are generally well tolerated, the particulate forms showing a higher incidence of undesirable side effects. Taken together, the hematopoiesis-stimulating properties of β-glucans predetermine these biological response modifiers to ever increasing use in human medicinal practice.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028052
- 003
- CZ-PrNML
- 005
- 20121207123424.0
- 007
- ta
- 008
- 120817e20110915sz f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules16097969 $2 doi
- 035 __
- $a (PubMed)21921869
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hofer, Michal $u Laboratory of Experimental Hematology, Institute of Biophysics, vvi, Academy of Sciences of the Czech Republic, Královopolská 135, CZ-61265 Brno, Czech Republic. hofer@ibp.cz
- 245 10
- $a Modulation of animal and human hematopoiesis by β-glucans: a review / $c M. Hofer, M. Pospíšil,
- 520 9_
- $a β-glucans are cell wall constituents of bacteria, yeast, fungi, and plants. They are not expressed in mammalian cells, but they are recognized by mammalian cells as pathogen-associated molecular patterns by pattern recognition receptors and thus act as biological response modifiers. This review summarizes data on the hematopoiesis-stimulating effects of β-glucans, as well as on their ability to enhance bone marrow recovery after an injury. β-glucans have been shown to support murine hematopoiesis suppressed by ionizing radiation or cytotoxic anti-cancer therapy. They also enhance stem cell homing and engraftment. Basically, two forms of β-glucan preparations have been investigated, namely particulate and soluble ones. β-glucans are generally well tolerated, the particulate forms showing a higher incidence of undesirable side effects. Taken together, the hematopoiesis-stimulating properties of β-glucans predetermine these biological response modifiers to ever increasing use in human medicinal practice.
- 650 _2
- $a anemie $x chemicky indukované $x farmakoterapie $7 D000740
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x škodlivé účinky $7 D000970
- 650 _2
- $a lékové formy $7 D004304
- 650 _2
- $a hematinika $x škodlivé účinky $x farmakologie $x terapeutické užití $7 D006397
- 650 _2
- $a hematopoéza $x účinky léků $x účinky záření $7 D006410
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a radioterapie $x škodlivé účinky $7 D011878
- 650 _2
- $a beta-glukany $x škodlivé účinky $x farmakologie $x terapeutické užití $7 D047071
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pospíšil, Milan
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 16, č. 9 (20110915), s. 7969-79
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21921869 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207123458 $b ABA008
- 999 __
- $a ok $b bmc $g 950094 $s 785398
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 16 $c 9 $d 7969-79 $e 20110915 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20120817/11/04